A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

Active, not recruitingOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

May 22, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

March 31, 2026

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Sodium stibogluconate / paramomycin

Treatment with Sodium stibogluconate / paramomycin

Trial Locations (1)

Unknown

KEMRI, Nairobi

Sponsors
All Listed Sponsors
collaborator

University of Gondar

OTHER

collaborator

Kenya Medical Research Institute

OTHER

collaborator

Makerere University

OTHER

collaborator

University of Khartoum

OTHER

collaborator

European Vaccine Initiative

OTHER

collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

lead

University of York

OTHER